The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.
D016915:AIDS Vaccines / Q000191:economics / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards; D002986:Clinical Trials as Topic; D015195:Drug Design; D014943:Global Health; D015658:HIV Infections / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control; D006295:Health Resources / Q000191:economics / Q000458:organization & administration; D006801:Humans; D007221:Industry
D016915:AIDS Vaccines
J Exp Med. 2008 Dec 22;205(13):3119-31
19047440
Science. 2010 Jun 11;328(5984):1359-60
20538936
PLoS Med. 2005 Feb;2(2):e25
15740411
Nat Med. 2009 Mar;15(3):293-9
19219024
Lancet. 2007 Nov 17;370(9600):1665
18022020
AIDS. 2009 Jan 2;23(1):3-8
19050380
Nat Rev Immunol. 2010 Jan;10(1):11-23
20010788
Immunity. 2008 Dec 19;29(6):835-8
19100694
Curr Opin HIV AIDS. 2009 Sep;4(5):431-40
20048708
Nature. 2007 Sep 6;449(7158):101-4
17805298
Nat Med. 2007 Jan;13(1):100-6
17187074
Nature. 2010 Mar 11;464(7286):217-23
20220840
Science. 2003 Jun 27;300(5628):2036-9
12829768
J Virol. 2010 Jul;84(14):7161-73
20444898
AIDS. 2010 May 15;24(8):1095-105
20400885
Nature. 2010 Mar 11;464(7286):224-31
20220841
Curr Opin HIV AIDS. 2009 Jul;4(4):247-52
19532060
N Engl J Med. 2008 Aug 28;359(9):888-90
18753644
J Virol. 2004 Mar;78(6):3140-4
14990733
J Infect Dis. 2009 Oct 15;200(8):1194-201
19754311
Curr Opin HIV AIDS. 2009 Sep;4(5):352-7
20048697
Nature. 2009 Oct 15;461(7266):908-15
19829370
Nat Immunol. 2009 Jan;10(1):116-125
19029902
AIDS. 2009 May 15;23(8):897-906
19414990
Nature. 2010 May 20;465(7296):350-4
20445539
Nat Rev Immunol. 2009 Oct;9(10):741-7
19763148
Science. 2009 Oct 9;326(5950):285-9
19729618
N Engl J Med. 2009 Dec 3;361(23):2209-20
19843557
PLoS Med. 2007 Dec;4(12):e348
18052607
PLoS One. 2010 Jan 20;5(1):e8805
20098712
PLoS Med. 2008 Apr 1;5(4):e81
18384232
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
18490657
PLoS Genet. 2009 Dec;5(12):e1000791
20041166
Science. 2010 Aug 13;329(5993):856-61
20616233